The Mayo Clinic is strengthening its longstanding partnership with GE Healthcare by embarking on a series of new joint research and development initiatives. These endeavors will focus on the application of digital imaging and theranostics, with the overarching aim of advancing Mayo Clinic’s research efforts closer to the commercial healthcare market.
“We are at a critical time in healthcare – technology is rapidly evolving, and we have a responsibility to drive healthcare capabilities through clinical translation and adoption of advanced technologies. This collaboration brings our research and clinical teams’ expertise and feedback closer to product development and commercialization of innovation, ultimately accelerating the rate of translation of our research to patient care and offering greater opportunity for global impact.”
– Matthew Callstrom, M.D., Ph.D., chair of Radiology at Mayo Clinic in Rochester, Minnesota
This collaboration signifies a concerted effort to bridge the gap between research and the commercialization of innovative healthcare solutions. By pooling their research and clinical expertise, the Mayo Clinic and GE Healthcare aspire to expedite the translation of research findings into practical patient care applications, thereby increasing their global impact.
The joint initiatives encompass a wide spectrum of activities, including the development of novel MRI (Magnetic Resonance Imaging) technologies and techniques, some of which leverage artificial intelligence-powered applications. The focus extends to enhancing cancer diagnostics and treatment, with a particular emphasis on achieving more precise tumour imaging and optimising radiation therapy planning. Additionally, the partnership explores the utilisation of targeted theranostic agents and seeks to improve the efficiency of radioactive isotope manufacturing.
Furthermore, the collaboration aims to streamline the process of conducting diagnostic and interventional ultrasound exams. This involves the integration of AI, automation, and other digital tools to ensure consistent and standardised care delivery across diverse patient populations and healthcare providers.
The joint efforts will be centred at the Mayo Clinic’s campus in Rochester, Minnesota, and will span a broad array of radiological disciplines, encompassing nuclear medicine, oncology, radiation oncology, cardiology, vascular care, neurology, and urology. By fostering synergy between research and healthcare innovation, the Mayo Clinic and GE Healthcare anticipate making significant strides in advancing healthcare technologies and ultimately improving patient outcomes.
“Mayo Clinic is globally acknowledged to be among the best in healthcare and care innovation. By collaborating with their scientists, inventors and healthcare providers, we will accelerate innovation and increase the clinical impact of our technologies beyond what either of our organizations could achieve independently.”
– Jan Makela, president and CEO of Imaging, GE HealthCare
